Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
11.04
+0.06 (0.55%)
At close: Dec 5, 2025, 4:00 PM EST
11.32
+0.28 (2.54%)
After-hours: Dec 5, 2025, 5:11 PM EST
Contineum Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 322 | 378 | - | - | - |
| Enterprise Value | 145 | 164 | - | - | - |
| Last Close Price | 11.04 | 14.65 | - | - | - |
| PB Ratio | 1.79 | 1.91 | - | - | - |
| P/TBV Ratio | 1.79 | 1.91 | - | - | - |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.01 | 0.15 | 0.08 |
| Debt / EBITDA Ratio | - | - | 0.03 | - | - |
| Debt / FCF Ratio | - | - | 0.03 | - | - |
| Asset Turnover | - | - | 0.55 | - | - |
| Quick Ratio | 28.68 | 20.53 | 22.83 | 6.26 | 18.78 |
| Current Ratio | 29.07 | 20.69 | 23.29 | 6.41 | 18.99 |
| Return on Equity (ROE) | -30.40% | -26.19% | 27.71% | -48.09% | - |
| Return on Assets (ROA) | -20.89% | -18.54% | 11.10% | -23.44% | - |
| Return on Capital (ROIC) | -21.42% | -19.30% | 11.79% | -25.44% | - |
| Return on Capital Employed (ROCE) | -36.90% | -25.10% | 12.90% | -52.70% | -42.90% |
| Earnings Yield | -18.43% | -11.19% | - | - | - |
| FCF Yield | -16.40% | -8.83% | - | - | - |
| Buyback Yield / Dilution | -96.27% | -469.95% | -51.38% | -6.35% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.